362 related articles for article (PubMed ID: 22884152)
1. Culture supernatants of breast cancer cell line MDA-MB-231 treated with parthenolide inhibit the proliferation, migration, and lumen formation capacity of human umbilical vein endothelial cells.
Li CJ; Guo SF; Shi TM
Chin Med J (Engl); 2012 Jun; 125(12):2195-9. PubMed ID: 22884152
[TBL] [Abstract][Full Text] [Related]
2. Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
Li C; Guo S; Shi T
Cell Biochem Funct; 2013 Apr; 31(3):263-8. PubMed ID: 23086737
[TBL] [Abstract][Full Text] [Related]
3. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
Cui P; Yu M; Peng X; Dong L; Yang Z
J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
[TBL] [Abstract][Full Text] [Related]
4. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs.
El-Aarag BY; Kasai T; Zahran MA; Zakhary NI; Shigehiro T; Sekhar SC; Agwa HS; Mizutani A; Murakami H; Kakuta H; Seno M
Int Immunopharmacol; 2014 Aug; 21(2):283-92. PubMed ID: 24859059
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
Hamsa TP; Kuttan G
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
[TBL] [Abstract][Full Text] [Related]
10. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
11. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Oct; 668(3):450-8. PubMed ID: 21839074
[TBL] [Abstract][Full Text] [Related]
12. Antimyeloma effects of resveratrol through inhibition of angiogenesis.
Hu Y; Sun CY; Huang J; Hong L; Zhang L; Chu ZB
Chin Med J (Engl); 2007 Oct; 120(19):1672-7. PubMed ID: 17935668
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effects of melatonin in endothelial cell cultures.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
Microvasc Res; 2013 May; 87():25-33. PubMed ID: 23473980
[TBL] [Abstract][Full Text] [Related]
15. Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2011 Aug; 9(8):1030-41. PubMed ID: 21665940
[TBL] [Abstract][Full Text] [Related]
16. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
17. Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro.
Nathwani SM; Hughes L; Greene LM; Carr M; O'Boyle NM; McDonnell S; Meegan MJ; Zisterer DM
Oncol Rep; 2013 Feb; 29(2):585-94. PubMed ID: 23232969
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
19. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
Wang D; Tang F; Wang S; Jiang Z; Zhang L
Cancer Chemother Pharmacol; 2012 Jan; 69(1):173-83. PubMed ID: 21638122
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of angiogenesis by hydroalcoholic extract of oak (Quercus infectoria) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion.
Yarani R; Mansouri K; Mohammadi-Motlagh HR; Mahnam A; Emami Aleagha MS
Pharm Biol; 2013 Mar; 51(3):361-8. PubMed ID: 23137183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]